Access Bio Accused Of Breaching $120M COVID Test Kit Deal
Intrivo Diagnostics Inc. slapped the maker of its COVID-19 tests with a breach of contract suit that accuses Access Bio Inc. of reneging on a $120 million production and distribution deal...To view the full article, register now.
Already a subscriber? Click here to view full article